SCHEMBL27420437

SCHEMBL27420437

C=C1N(CC)CCN1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14402164 0.78 INMT (0.33) —
SCHEMBL27420434 0.76 — —
SCHEMBL13555502 0.74 DPP4 (0.35) —
SCHEMBL11982537 0.74 INMT (0.34) —
Hydrochloric Acid SCHEMBL14244165 0.72 — —
SCHEMBL13698601 0.72 GAA (0.39) —
SCHEMBL4340781 0.70 — —
SCHEMBL21946652 0.70 — —
SCHEMBL14244166 0.69 — —
SCHEMBL8242236 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217952-A1 TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN POSEIDON INNOVATION 1, INC. 2024-07-04 — — US disclosed
Send feedback